MLECNasdaqFood and Kindred ProductsFiscal year ends June 30Also trades as MLECW
Moolec Science SA
Financials through Q2 FY2025, quarter ended Dec 31, 2024Last filing: 20-F on Dec 29, 2025
$1.53−0.15 (-8.63%)
Close on Oct 19, 2026
- Market cap
- $59.81M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$8.21 (−84.26%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Moolec Science SA grew revenue 521.5% to $5.63M over fiscal 2024. Free cash flow was -$9.49M.
Revenue
$5.63M
+521.5% vs. a year earlier
Operating income
-$9.04M
FY2024
Free cash flow
-$9.49M
FY2024
EPS, diluted
-$0.19
FY2024
Key statistics
Valuation at the latest close; fundamentals over fiscal 2024, balances at Dec 31, 2024
Valuation
- Market cap
- $59.81M
- P/E ratio
- –
- Price to sales
- 10.63
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -15.86%
Fundamentals
- Revenue
- $5.63M
- EPS, diluted
- -$0.19
- Free cash flow
- -$9.49M
- Diluted shares
- 39M
Three years at a glance
Fiscal years 2022 to 2024, USD
Revenue
$5.63M+521.5% YoY
Gross profit
$472.58K
Operating income
-$9.04M
EPS, diluted
-$0.19
Free cash flow
-$9.49M
Reported period